Algernon Pharmaceuticals Market Cap

Algernon Pharmaceuticals has a market cap or net worth of $1.75 million as of June 18, 2025. Its market cap has decreased by -8.02% in one year.

Market Cap

1.75M

Enterprise Value

1.69M

Revenue

n/a

Ranking

n/a

PE Ratio

9.40

Stock Price

$0.05

Market Cap Chart

Since February 1, 2016, Algernon Pharmaceuticals's market cap has decreased from 12.66M to 1.75M, a decrease of -86.15%. That is a compound annual growth rate of -19.00%.

Market Cap History

Date	Market Cap	% Change
Jun 17, 2025	1.48M	11.47%
Dec 31, 2024	1.33M	38.32%
Dec 29, 2023	960.22K	-74.54%
Dec 30, 2022	3.77M	-30.49%
Dec 31, 2021	5.43M	-77.97%
Dec 31, 2020	24.63M	709.53%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Elite Pharmaceuticals	790.52M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	437.04M
Northwest Biotherapeutics	403.91M
Glass House Brands	398.13M

Market Cap Rankings